Oncotype DX® in breast cancer patients: clinical experience, outcome and follow-up-a case-control study.

Michelle G RathLorenz UhlmannMarita FiedlerJoerg HeilMichael GolattaChristine DinkicAndre HennigsSarah SchottVeronika ErnstThorsten KochChristof SohnCosima BruckerJoachim Rom

Published in: Archives of gynecology and obstetrics (2017)

Oncotype DX® testing can be recommended for risk-tailored chemotherapy. Results should be validated in larger prospective studies.

Keyphrases

locally advanced
smoking cessation
rectal cancer